“UCD spinout drug company Atxa Therapeutics, which is developing novel therapies that tackle a deadly heart condition, is seeking to raise $30 million to bring its treatment through clinical trials and secure regulatory approval …” (more)
[Ciarán Hancock, Irish Times, 27 July]